W
Wolfgang Schroeder
Researcher at University of Cologne
Publications - 27
Citations - 707
Wolfgang Schroeder is an academic researcher from University of Cologne. The author has contributed to research in topics: Medicine & Esophagectomy. The author has an hindex of 6, co-authored 17 publications receiving 386 citations.
Papers
More filters
Journal ArticleDOI
Benchmarking Complications Associated with Esophagectomy.
Donald E. Low,Madhan Kumar Kuppusamy,Derek Alderson,Ivan Cecconello,Andrew C. Chang,Gail Darling,Andrew Davies,Xavier Benoit D’Journo,Suzanne S. Gisbertz,S. Michael Griffin,Richard H. Hardwick,Arnulf H. Hoelscher,Wayne L. Hofstetter,Blair A. Jobe,Yuko Kitagawa,Simon Law,Christophe Mariette,Nick Maynard,Christopher R. Morse,Philippe Nafteux,Manuel Pera,C S Pramesh,Sonia Puig,John V. Reynolds,Wolfgang Schroeder,Mark Smithers,Bas P. L. Wijnhoven +26 more
TL;DR: Standardized methods provide contemporary international benchmarks for reporting outcomes after esophagectomy, using a standardized dataset with specific definitions to prospectively collect international data to provide a benchmark for complications and outcomes associated with esphagectomy.
Journal ArticleDOI
Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.
S Brinkmann,Wolfgang Schroeder,Kristina Junggeburth,Christian A. Gutschow,Marc Bludau,Arnulf H. Hoelscher,Jessica M. Leers +6 more
TL;DR: In patients with high-output chylous fistula, an early rethoracotomy with repeat ligation of the thoracic duct is safe and helps to shorten recovery time and in cases of low-volume drainage, a conservative approach is feasible.
Journal ArticleDOI
Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Simon Schallenberg,Julian Bork,Ahlem Essakly,Hakan Alakus,Reinhard Buettner,Axel M. Hillmer,Christiane J. Bruns,Wolfgang Schroeder,Thomas Zander,Heike Loeser,Florian Gebauer,Alexander Quaas +11 more
TL;DR: This work describes, for the first time, loss of one of the SWI/SNF ATPase subunit proteins in a large number of adenocarcinomas of the oesophagus.
Journal ArticleDOI
PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis.
Ahlem Essakly,Heike Loeser,Max Kraemer,Hakan Alakus,Seung-Hun Chon,Thomas Zander,Reinhard Buettner,Axel M. Hillmer,Christiane Bruns,Wolfgang Schroeder,Florian Gebauer,Alexander Quaas +11 more
TL;DR: These findings are the first to link the KRAS amplified genotypes with lymphonodal positivity and poor prognosis and the PIK3CA-amplified genotype with a T cell–rich microenvironment in EAC and whether these two genotype subgroups can be therapeutically influenced.
Journal ArticleDOI
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma.
Svenja Wagener-Ryczek,Max Schoemmel,Max Kraemer,Christiane Bruns,Wolfgang Schroeder,Thomas Zander,Florian Gebauer,Hakan Alakus,Sabine Merkelbach-Bruse,Reinhard Buettner,Heike Loeser,Martin Thelen,Hans A. Schlößer,Alexander Quaas +13 more
TL;DR: Analysis of immune profiles of primary resected and neoadjuvant treated esophageal adenocarcinoma reveals a down-regulation of nearly all important checkpoint markers and inflammatory related genes in the local microenvironment and unravels possible targets for immunotherapy.